Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
LOS ANGELES, April 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Gossamer Bio, Inc., (“Gossamer” or the "Company") (NASDAQ: GOSS) investors of a class action on behalf of investors that...
-
Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
LOS ANGELES, April 23, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Gossamer Bio, Inc., (“Gossamer” or the "Company") (NASDAQ: GOSS) investors of a class action on behalf of investors that...
-
Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
Investors who lost money in GOSS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm